Ora is the world’s leading full-service ophthalmic CRO and product development firm with offices in the United States, the United Kingdom and Japan. Over the past 30 years, we helped our clients earn 41 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora’s pre-clinical and clinical models, unique methodologies and regulatory strategies have been refined and proven across thousands of projects. We bring together the world’s most extensive and experienced team of ophthalmic experts and R&D professionals to maximize the value of new product initiatives.
Dr. Hollander joins Ora after 10 years as industry leader at Allergan. Meet Ora’s New Chief Medical Officer at ARVO
Research has led to better, more diverse ways to reach a diagnosis, let alone more knowledge about DED itself.
A look at the etiology, signs and symptoms of blepharitis, as well as strategies for treatment.
Ora, ophthalmic leader, deepens European foothold as part of Global expansion